In the field of molecular biology and biochemical research, the term ea peptide serves as The present invention relates to anepitope tag useful in affinity-based applications. The invention further includes fusion proteins, methods for preparing Read more a focal point for various specialized studies. Whether one is exploring synthetic tetrapeptides or investigating the n An Ephrin Mimetic Peptide That Selectively Targets the uances of MHC class II interactions, the diversity of these compounds is remarkable. As someone who follows advancements in laboratory-grade reagents, I have found that distinguishing between specific sequences and their functional roles is essential for any rigorous investigative work.
The Specificity of Ea (52–68)
One of the most frequently referenced sequences in literature is the MHC II Ea chain (Ea) (52–68) peptide. With a defined amino acid composition of ASFEAQGALANIAVDKA, this peptide has become a standard tool for researchers studying antigen presentation. It is often observed that this self Ea peptide occupies a significant portion of natural I-Ab molecules, making it a critical reference point.
When working with Ea peptide (Ea 52-68), researchers often utilize specialized reagents, such as the Ea52-68 peptide bound to I-Ab Antibody FITC. This specific monoclonal antibody which binds YAe antigen on B cells and other antigen-presenting cells provides a clear visual indicator in flow cytometr Ea52-68 peptide bound to I-Ab Antibody FITC from Thermo y and related assays. It is important to note that this interaction is highly specific; for instance, the YAe antibody recognizes the co Secure, centralized workspaces and advanced AI features help academic, government, and corporate research teams manage evolving protocols, optimize workflow Read more mplex but does not bind effectively to the peptide when presented by I-Ak or I-Abm-12 molecules.
Beyond the Standard: Structural Diversity
While the 52–68 sequence is well-characterized, t MHC Class II Antibody (YAe) [FITC] (NBP1-43948) he broader category of peptides encompasses a vast array of structures. For example, Ea-230 is a synthetic tetrapeptide with a unique sequence (Ala-Gln-Gly-Val). This contrasts sharply with EA2, which is a biological active peptide serving as a substrate for polypeptide N-a EA2 is a biological active peptide. (This is a peptide substrate for polypeptide N-acetylgalactosaminyltransferase (polypeptide GalNAc-T).) cetylgalactosaminyltransferase. These examples highlight why it is vital to verify the exact peptide Ea sequence before initiating any experimental protocol.
Furthermore, the application of these molecules extends into modern engineering. We see epitope tag useful in affinity-based applications being integrated into protein studies, as well as the innovative use of AIE molecules and peptides to enhance diagnostic sensitivity. The ability to perform engineering peptide synthesis has opened doors to creating mimetic sequences that target specific domains, such as those that target the ligand-binding domain of EphA2.
Research Considerations and Observations
In my own review of available literature, I have encountered various forms of peptide EA, ranging from those derived from the Eα52-68, a peptide derived from the Ea gene to complex AGE/peptides are highly reactive species involved in tissue modification studies.
When searching for the class II MHC Eα chain (Eα) (52–68) peptide, one must be mindful of the purity and the specific binding conditions required for success. Whether you are conducting uptake assays or using Eα (52-68) is a specific peptide sequence for structural analysis, the consistency of the source material is paramount.
Conclusion
The exploration of the ea peptide and its derivatives remains a dynamic area of study. By understanding the distinct roles of these molecules—from serving as markers in MHC research to acting as functional substrates—scientists can better navigate the c by DL Johnson·1998·Cited by 141—A 13 amino acidpeptidewas identified which possesses mimetic properties and contains a minimal agonist epitope.Read more omplexities of molecular interactions. Always ensure that the specific Ea peptide variant aligns with your experimental requirements, as the difference between a truncated sequence and a full-length peptide can significantly alter your results.